127 related articles for article (PubMed ID: 7507045)
1. Neoadjuvant hormonal deprivation before radical prostatectomy.
Schulman CC; Sassine AM
Eur Urol; 1993; 24(4):450-5. PubMed ID: 7507045
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant hormonal deprivation before radical prostatectomy.
Sassine AM; Schulman CC
Eur Urol; 1993; 24 Suppl 2():46-50. PubMed ID: 7505231
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant hormonal deprivation before radical prostatectomy.
Schulman CC; Sassine AM
Clin Invest Med; 1993 Dec; 16(6):523-31. PubMed ID: 7516836
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review.
Schulman CC
Prostate Suppl; 1994; 5():9-14. PubMed ID: 7513532
[TBL] [Abstract][Full Text] [Related]
5. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
[TBL] [Abstract][Full Text] [Related]
6. Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen.
Soloway MS; Hachiya T; Ruiz HE; Gomez CC; Civantos F
World J Urol; 1993; 11(4):221-6. PubMed ID: 7508788
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors in patients with prostatic cancer treated with neoadjuvant hormonal therapy and radical prostatectomy].
Villavicencio Mavrich H; Chéchile Toniolo G; Salinas Duffo D; Muñoz Plaza J; Sorraca Ibáñez YJ
Arch Esp Urol; 1996 Oct; 49(8):797-806. PubMed ID: 9065276
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant hormonal therapy for prostate cancer].
Miyakita H
Nihon Rinsho; 2005 Feb; 63(2):309-13. PubMed ID: 15714984
[TBL] [Abstract][Full Text] [Related]
9. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
Oesterling JE; Andrews PE; Suman VJ; Zincke H; Myers RP
J Urol; 1993 Apr; 149(4):779-82. PubMed ID: 7681117
[TBL] [Abstract][Full Text] [Related]
10. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of the serum PSA level in patients having undergone neo-adjuvant hormone treatment before radical prostatectomy].
Wildschutz T; Janssen T; Schulman C
Acta Urol Belg; 1995 Mar; 63(1):79-82. PubMed ID: 7537012
[TBL] [Abstract][Full Text] [Related]
12. PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group.
McLeod DG; Johnson CF; Klein E; Peabody JO; Coffield S; Soloway M
Urology; 1997 Mar; 49(3A Suppl):70-3. PubMed ID: 9123740
[TBL] [Abstract][Full Text] [Related]
13. Effects of androgen deprivation prior to radical prostatectomy in 375 patients.
Tunn UW; Acar O; Goldschmidt AJ
Urol Int; 1996; 56 Suppl 1():6-12. PubMed ID: 8776811
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant hormonal therapy prior to radical prostatectomy: evaluation of pathological downstaging and biochemical relapse.
Kiriyama I; Ogaki K; Ohba S; Nishimura T
J Nippon Med Sch; 2002 Oct; 69(5):422-7. PubMed ID: 12382001
[TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.
Soloway MS; Hachiya T; Civantos F; Murphy WM; Gomez CC; Ruiz HE
Urology; 1994 Feb; 43(2 Suppl):52-6. PubMed ID: 7509535
[TBL] [Abstract][Full Text] [Related]
16. Maximum androgen deprivation prior to radical retropubic prostatectomy in patients with stage T3 adenocarcinoma of the prostate.
Voges GE; Mottrie AM; Fichtner J; Mappes C; Störkel S; Stöckle M; Hohenfellner R
Eur Urol; 1995; 28(3):209-14. PubMed ID: 8536774
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.
Eulau SM; Tate DJ; Stamey TA; Bagshaw MA; Hancock SL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):735-40. PubMed ID: 9652832
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant hormonal therapy: the Canadian experience.
Labrie F; Cusan L; Gomez JL; Diamond P; Suburu R; Lemay M; Tetu B; Fradet Y; Bélanger A; Candas B
Urology; 1997 Mar; 49(3A Suppl):56-64. PubMed ID: 9123738
[TBL] [Abstract][Full Text] [Related]
19. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
Abbas F; Kaplan M; Soloway MS
Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Witjes WP; Schulman CC; Debruyne FM
Urology; 1997 Mar; 49(3A Suppl):65-9. PubMed ID: 9123739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
